Myasthenia gravis and covid-19 in pregnancy: a review of the literature and case series report

References

• Bansal R, Goyal MK, Modi M. Management of myasthenia gravis during pregnancy. Indian J Pharmacol. 2018;50(6):302–308.
   PubMed Web of Science ®Google Scholar
• Je G, Ghasemi M. Myasthenia gravis and pregnancy. WJOG. 2020;9(1):1–10.
   Google Scholar
• Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev. 2012;11(6–7):A479–A485.
   PubMed Web of Science ®Google Scholar
• Leker RR, Karni A, Brenner T, et al. Effects of sex hormones on experimental autoimmune myasthenia gravis. Eur J Neurol. 2000;7(2):203–206.
   PubMed Web of Science ®Google Scholar
• Li Y, Xiao B, Xiao L, et al. Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen. Intern Med. 2010;49(6):611–613.
   PubMed Web of Science ®Google Scholar
• WHO official updates | Coronavirus disease 2019 [cited 2021 July 12]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
   Google Scholar
• Jaretzki A, 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of america. Neurology. 2000;55(1):16–23.
   PubMed Web of Science ®Google Scholar
• National consensus protocol. http://ww w.nevrologiabg.com/wp-content/uploads/2021/03/Consensus-Myasthenia-Gravis-BG.pdf (Bulgarian).
   Google Scholar
• Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273–2282.
   PubMed Web of Science ®Google Scholar
• Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375(26):2570–2581.
   PubMed Web of Science ®Google Scholar
• Carr AS, Cardwell CR, McCarron PO, et al. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Esposito F, Biamonti M, et al. Myasthenia gravis during pregnancy. Expert Rev Neurother. 2008;8(6):979–988.
   PubMedGoogle Scholar
• Djelmis J, Sostarko M, Mayer D, et al. Myasthenia gravis in pregnancy and birth: report on 69 cases. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):21–25.
   PubMed Web of Science ®Google Scholar
• Ducci RD, Lorenzoni PJ, Kay CS, et al. Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord. 2017;27(4):352–357.
   PubMed Web of Science ®Google Scholar
• Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol. 2007;14(1):38–43.
   PubMed Web of Science ®Google Scholar
• Dominovic-Kovacevic A, Ilic T, Vukojevic Z. Myasthenia gravis and pregnancy – case report. Curr Top Neurol Psychiatr Relat Discip. 2010;18:40–43.
   Google Scholar
• Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87(4):419–425.
   PubMed Web of Science ®Google Scholar
• Cozzani E, Cioni M, Gariazzo L, et al. The management of autoimmune diseases in preconception, pregnancy and lactation. G Ital Dermatol Venereol. 2019;154(3):299–304.
   PubMed Web of Science ®Google Scholar
• Hammad I, Porter TF. An update on biologic agents during pregnancy. Clin Perinatol. 2020;47(4):733–742.
   PubMed Web of Science ®Google Scholar
• Thai TN, Sarayani A, Wang X, et al. Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: a retrospective cohort study. Pharmacoepidemiol Drug Saf. 2020;29(6):716–724.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Pretta S, Nicoletti A, et al. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;121(2):129–138.
   PubMed Web of Science ®Google Scholar
• Gur C, Diav-Citrin O, Shechtman S, et al. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18(1):93–101.
   PubMed Web of Science ®Google Scholar
• Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385–392.
   PubMedGoogle Scholar
• Gaudier FL, Santiago-Delpin E, Rivera J, et al. Pregnancy after renal transplantation. Surg Gynecol Obstet. 1988;167(6):533–543.
   PubMedGoogle Scholar
• Schinzel H, Berghoff K, Beuermann I, et al. Anticoagulation with low-molecular-weight heparin (dalteparin) in plasmapheresis therapy: initial experience. Transfusion. 2006;46(4):624–629.
   PubMed Web of Science ®Google Scholar
• D'Souza R, Malhamé I, Teshler L, et al. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand. 2020;99(9):1110–1120.
   PubMed Web of Science ®Google Scholar
• Chow JH, Khanna AK, Kethireddy S, et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg. 2021;132(4):930–941.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, HLH Across Speciality Collaboration, UK, et al. HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019;2019(2):CD004659.
   PubMedGoogle Scholar
• Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. PARIS collaborative group. Lancet. 2007;369(9575):1791–1798.
   PubMed Web of Science ®Google Scholar
• Henderson JT, Whitlock EP, O'Connor E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive services task force. Ann Intern Med. 2014;160(10):695–703.
   PubMed Web of Science ®Google Scholar
• Ahrens KA, Silver RM, Mumford SL, et al. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol. 2016;127(4):689–698.
   PubMed Web of Science ®Google Scholar
• University of Oxford. Recovery; randomised evaluation of COVID-19 therapy. [2021 July 30] https://www.recoverytrial.net/.
   Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of covid-19 — final report. N Engl J Med. 2020;383(19):1813–1826.
   PubMed Web of Science ®Google Scholar
• Pan H, Peto R, Karim QA, et al. Repurposed antiviral drugs for COVID-19 – interim WHO SOLIDARITY trial results. N Engl J Med. 2021;384:497–511.
   Google Scholar
• Jiménez-Lozano I, Caro-Teller JM, Fernández-Hidalgo N, et al. Safety of tocilizumab in COVID-19 pregnant women and their newborn: a retrospective study. J Clin Pharm Ther. 2021;46(4):1062–1070.
   PubMed Web of Science ®Google Scholar
• Furtado RHM, Berwanger O, Fonseca HA, et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. The Lancet. 2020;396(10256):959–967.
   PubMed Web of Science ®Google Scholar
• Costamagna G, Abati E, Bresolin N, et al. Management of patients with neuromuscular disorders at the time of the SARS- CoV- 2 pandemic. J Neurol. 2020;17:1–12.
   Google Scholar
• Camelo- Filho AE, Silva AMS, Estephan EP, et al. Myasthenia gravis and COVID- 19: clinical characteristics and outcomes. Front Neurol. 2020;11:1053.
   PubMed Web of Science ®Google Scholar
• Aksoy E, Oztutgan T. COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature. Case Rep Infect Dis. 2020; 2020:8845844.
   PubMed Web of Science ®Google Scholar
• Ozcan J, Balson IF, Dennis AT. New diagnosis myasthenia gravis and preeclampsia in late pregnancy. BMJ Case Rep. 2015;2015:bcr2014208323.
   PubMedGoogle Scholar
• Cosma S, Carosso AR, Cusato J, et al. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. Am J Obstet Gynecol. 2021;224(4):391.e1–e7.
   PubMed Web of Science ®Google Scholar
• Almeida C, Coutinho E, Moreira D, et al. Myasthenia gravis and pregnancy: anaesthetic management-a series of cases. Eur J Anaesthesiol. 2010;27(11):985–990.
   PubMed Web of Science ®Google Scholar
• Hassoun M, El Turjuman U, Chokr I, et al. Myasthenia gravis in the neonate. NeoReviews. 2010;11(4):e200–e205.
   Google Scholar
• Rottenstreich A, Tsur A, Braverman N, et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Israel: a multicenter prospective analysis. Arch Gynecol Obstet. 2021;303(6):1401–1405.
   PubMed Web of Science ®Google Scholar
• Ferrazzi E, Frigerio L, Savasi V, et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis. BJOG: Int J Obstet Gy. 2020;127(9):1116–1121.
   PubMed Web of Science ®Google Scholar
• Gately R, San A, Kurtkoti J, et al. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab. Nephrology. 2017;22(Suppl 1):32–35.
   PubMedGoogle Scholar
• Midelfart Hoff J, Midelfart A. Maternal myasthenia gravis: a cause for arthrogryposis multiplex congenita. J Child Orthop. 2015;9(6):433–435.
   PubMedGoogle Scholar
• Norwood F, Dhanjal M, Hill M, et al. Myasthenia in pregnancy: best practice guidelines from a U.K. multispecialty working group. J Neurol Neurosurg Psychiatry. 2014;85(5):538–543.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Clinical management of COVID-19: interim guidance. Geneva, Switzerland: World Health Organization; 2020.
   Google Scholar